6-year treatment follow-up with an extended-release alkaline formulation (Sibnayal(®)) in primary distal renal tubular acidosis.

Bertholet-Thomas A, De Mul A, Bernardor J, Roussey-Kesler G, Podracka L, Novo R, Nobili F, Knebelmann B, Harambat J, Golubovic E, Boyer O, Di Maio M, Cailliez M, Baudouin V, Chidler L, Leblanc V, Bacchetta J

Open source

DOI
10.1186/s13023-025-03953-4
Published
2025 Aug 13
Container
Orphanet journal of rare diseases
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1186/s13023-025-03953-4,
  title = {6-year treatment follow-up with an extended-release alkaline formulation (Sibnayal(®)) in primary distal renal tubular acidosis.},
  author = {Bertholet-Thomas A and De Mul A and Bernardor J and Roussey-Kesler G and Podracka L and Novo R and Nobili F and Knebelmann B and Harambat J and Golubovic E and Boyer O and Di Maio M and Cailliez M and Baudouin V and Chidler L and Leblanc V and Bacchetta J},
  year = {2025},
  journal = {Orphanet journal of rare diseases},
  doi = {10.1186/s13023-025-03953-4},
  url = {https://doi.org/10.1186/s13023-025-03953-4}
}

RIS

TY  - JOUR
TI  - 6-year treatment follow-up with an extended-release alkaline formulation (Sibnayal(®)) in primary distal renal tubular acidosis.
AU  - Bertholet-Thomas A
AU  - De Mul A
AU  - Bernardor J
AU  - Roussey-Kesler G
AU  - Podracka L
AU  - Novo R
AU  - Nobili F
AU  - Knebelmann B
AU  - Harambat J
AU  - Golubovic E
AU  - Boyer O
AU  - Di Maio M
AU  - Cailliez M
AU  - Baudouin V
AU  - Chidler L
AU  - Leblanc V
AU  - Bacchetta J
PY  - 2025
JO  - Orphanet journal of rare diseases
DO  - 10.1186/s13023-025-03953-4
UR  - https://doi.org/10.1186/s13023-025-03953-4
ER  - 

APA

A, B., A, D. M., J, B., G, R., L, P., R, N., F, N., B, K., J, H., E, G., O, B., M, D. M., M, C., V, B., L, C., V, L., & J, B. (2025). 6-year treatment follow-up with an extended-release alkaline formulation (Sibnayal(®)) in primary distal renal tubular acidosis.. Orphanet journal of rare diseases. https://doi.org/10.1186/s13023-025-03953-4

Source records